Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Turkish Journal of Pharmaceutical Sciences|January 30, 2026
Overcoming Intrinsic and Acquired Temozolomide Resistance in Glioblastoma: Fisetin as a Potential Strategy to Enhance Sensitivity via ZEB1 ModulationSena Ferah, Mine Çamlıbel, Melis Erçelik, et al.
Journal of Neurological Surgery. Part B, Skull Base|December 3, 2013
Anatomic variation of the optic strut: classification schema, radiologic evaluation, and surgical relevanceRobert G Kerr, William D Tobler, James L Leach, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 19, 2017
Olea europaea leaf extract and bevacizumab synergistically exhibit beneficial efficacy upon human glioblastoma cancer stem cells through reducing angiogenesis and invasion in vitroGulcin Tezcan, Mevlut Ozgur Taskapilioglu, Berrin Tunca, et al.
Turkish Neurosurgery|May 5, 2023
Diabetes Mellitus-Mediated MALAT1 Expression Induces Glioblastoma AggressivenessAysen Akkurt Kocaeli, Secil Ak Aksoy, Melis Ercelik, et al.
Singapore Medical Journal|October 3, 2021
Diagnostic value of cerebrospinal fluid levels of D-lactate, tumour necrosis factor-alpha and interleukin-6, -8, and -17 in suspected nosocomial meningitisSibel Yorulmaz Goktas, Arzu Yılmaztepe Oral, Emel Yılmaz, et al.
American Journal of Cancer Research|September 19, 2014
Olea europaea leaf extract improves the treatment response of GBM stem cells by modulating miRNA expressionGulcin Tezcan, Berrin Tunca, Ahmet Bekar, et al.
Cellular and Molecular Neurobiology|April 3, 2014
microRNA expression pattern modulates temozolomide response in GBM tumors with cancer stem cellsGulcin Tezcan, Berrin Tunca, Ahmet Bekar, et al.
Neurological Research|September 17, 2021
Long non-coding RNAs as a predictive markers of group 3 medulloblastomasMelis Mutlu, Cagla Tekin, Secil Ak Aksoy, et al.
Pageof 6